Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Alfonso, Dueñas-González"'
Autor:
Berenice Prestegui Martel, Alma Delia Chávez-Blanco, Guadalupe Domínguez-Gómez, Alfonso Dueñas González, Patricia Gaona-Aguas, Raúl Flores-Mejía, Selma Alin Somilleda-Ventura, Octavio Rodríguez-Cortes, Rocío Morales-Bárcena, Alberto Martínez Muñoz, Cesar Miguel Mejia Barradas, Jessica Elena Mendieta Wejebe, José Correa Basurto
Publikováno v:
Molecules, Vol 29, Iss 15, p 3509 (2024)
In this work, we performed anti-proliferative assays for the compound N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) on breast cancer (BC) cells (MCF-7, SKBR3, and triple-negative BC (TNBC) MDA-MB-231 cells) to explore its pharmacological mechani
Externí odkaz:
https://doaj.org/article/a948e4b9f6f941f78c57e492e1d76e31
Autor:
Luis F. Oñate-Ocaña, Mayra Ponce-Martínez, Lucia Taja-Chayeb, Olga Gutiérrez-Hernández, Alejandro Avilés-Salas, David Cantú-de-León, Alfonso Dueñas-González, Myrna Candelaria-Hernández
Publikováno v:
Revista de Investigación Clínica, Vol 73, Iss 6 (2021)
Background: Novel prognostic factors in patients with diffuse large B-cell lymphoma (DLBCL) are required in the era of Rituximab. Objective: The objective of the study was to study the prognostic impact of exon-16 enhancer-of-zeste homolog-2 (EZH2) m
Externí odkaz:
https://doaj.org/article/6513ee05ea0740fd8c68b39e553d4c10
Autor:
Bryan J. Ager, Dolores Gallardo-Rincón, David Cantú de León, Adriana Chávez-Blanco, Linus Chuang, Alfonso Dueñas-González, Eva Gómez-García, Roberto Jerez, Anuja Jhingran, Mary McCormack, Linda Mileshkin, Carlos Pérez-Plasencia, Marie Plante, Andrés Poveda, David K. Gaffney
Publikováno v:
Gynecologic Oncology Reports, Vol 25, Iss , Pp 90-93 (2018)
Cervical cancer is the fourth most common cancer in women with 85% of the mortality burden occurring in less-developed regions of the world. The Cervix Cancer Research Network (CCRN) was founded by the Gynecologic Cancer InterGroup (GCIG) with a miss
Externí odkaz:
https://doaj.org/article/66ab383ffef34337b6ebc5a5264317ad
Autor:
David Méndez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamín García-Vázquez, Martiniano Bello, Itzia Irene Padilla-Martínez, Manuel Jonathan Fragoso-Vázquez, Alfonso Dueñas González, Nuria De Pedro, José Antonio Gómez-Vidal, Humberto Lubriel Mendoza-Figueroa, José Correa-Basurto
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1, p 49 (2021)
The implementation of chemo- and bioinformatics tools is a crucial step in the design of structure-based drugs, enabling the identification of more specific and effective molecules against cancer without side effects. In this study, three new compoun
Externí odkaz:
https://doaj.org/article/adf3f9207ef946e0acee2c9d6a74b139
Autor:
Enrique Pérez-Cárdenas, Ileana J Fernández-Domínguez, Catalina Trejo-Becerril, Joaquin Manzo-Merino, Alfonso Dueñas-González, Lucia Taja-Chayeb
Publikováno v:
Cancer Biol Ther
Nowadays, extracellular DNA or circulating cell-free DNA is considered to be a molecule with clinical applications (diagnosis, prognosis, monitoring of treatment responses, or patient follow-up) in diverse pathologies, especially in cancer. Neverthel
Publikováno v:
Current Medicinal Chemistry. 28:2085-2099
Complex common diseases are a significant burden for our societies and demand not only preventive measures but also more effective, safer, and more affordable treatments. The whole process of the current model of drug discovery and development implie
Publikováno v:
Seminars in Cancer Biology. 68:123-131
Drug repurposing for cancer therapy is currently a hot topic of research. Theoretically, in contrast to the known hurdles of developing new molecular entities, the approach of repurposing has several advantages. Mostly, it is said that it is faster,
Autor:
Enrique Pérez-Cárdenas, Lucía Taja-Chayeb, Catalina Trejo-Becerril, José Chanona-Vilchis, Alma Chávez-Blanco, Guadalupe Domínguez-Gómez, Elizabeth Langley, Alejandro García-Carrancá, Alfonso Dueñas-González
Publikováno v:
OncoTargets and Therapy. 15:845-846
Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, et al. Onco Targets Ther. 2018;11:8823–8833. The authors have advised that an error during the preparation of the slide images for Figure 2C, on page 8827, led to the inadvertent duplication of f
Drug repositioning is a alternative strategy to discover and develop anticancer drugs based on identification of new mechanisms of actions and indications for existing compounds. Ivermectin belongs to the avermectin group of compounds, a series of 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432f0f05a4df1de6832ef5ca78a2b908
https://mts.intechopen.com/articles/show/title/ivermectin-potential-repurposing-of-a-versatile-antiparasitic-as-a-novel-anticancer
https://mts.intechopen.com/articles/show/title/ivermectin-potential-repurposing-of-a-versatile-antiparasitic-as-a-novel-anticancer
Autor:
Guadalupe Dominguez-Gomez, L Taja-Chayeb, Aurora Gonzalez-Fierro, Catalina Trejo-Becerril, S Vidal-Millán, Adriana Romo-Pérez, Alma Chavez-Blanco, Alfonso Dueñas-González, Enrique Pérez-Cárdenas
Publikováno v:
Clinics and research in hepatology and gastroenterology. 46(4)
It is estimated that up to 10% of gastric carcinomas show familial aggregation. In contrast, around 1-3 % (approximately 33,000 yearly) are genuinely hereditary. Hereditary diffuse gastric cancer (HDGC) is a rare malignancy characterized by autosomal